AFT Pharmaceuticals rises to near 1-month high on Japan licensing deal for Maxigesic IV
Shares rise as much as 2.1% to NZ$4.48, their highest since August 31, after exclusive agreement with Mikasaseiyaku Co.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.